At the end of the 36-week tirzepatide lead-in period, participants achieved 21.1% mean WL
Dysaesthesia, an abnormal sensory condition, occurred in more than 12% of patients at the highest dose, consistent with earlier retatrutide studies
GLP-1 receptor agonists do not cause disproportionate muscle loss relative to fat, and the muscle that remains often improves in quality and function, making muscle gain achievable with proper training and nutrition
A comprehensive comparison of LRYGB and LSG in obese patients including the effects on QoL, comorbidities, weight loss, and complications: a systematic review and meta-analysis
The exact amount of berberine is not disclosed because it is a proprietary blend
GLP-1 stands for glucagon-like peptide 1, a hormone released by your gut in response to food